An in-depth look to ORUKA THERAPEUTICS INC operating, investing, and financing activities

HQ1 free cash flow for Q3 24 is -31.46 M EUR. For 2023, HQ1 free cash flow was -4.54 M EUR and operating cash flow was -4.54 M EUR.